Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshizaki, T.
Right arrow Articles by Furukawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshizaki, T.
Right arrow Articles by Furukawa, M.
Clinical Cancer Research Vol. 7, 1946-1951, July 2001
© 2001 American Association for Cancer Research


Regular Articles

Induction of Interleukin-8 by Epstein-Barr Virus Latent Membrane Protein-1 and Its Correlation to Angiogenesis in Nasopharyngeal Carcinoma

Tomokazu Yoshizaki1, Toshiyuki Horikawa, Ren Qing-chun, Naohiro Wakisaka, Hajime Takeshita, Tzung-Shiahn Sheen, Shiann-Yann Lee, Hiroshi Sato and Mitsuru Furukawa

Department of Otolaryngology, School of Medicine [T. Y., T. H., R. Q-C., N. W., H. T., M. F.] and Department of Molecular Oncology and Virology, Cancer Research Institute [R. Q-C., H. S.], Kanazawa University, Kanazawa 920-8641, Japan, and Department of Otolaryngology, School of Medicine, National Taiwan University, Taipei 10016, Taiwan, Republic of China [T-S. S., S-Y. L.]

Purpose: The EBV latent membrane protein-1 (LMP-1) is a multifunctional protein. Recently, the contribution of LMP-1 to the metastasis of nasopharyngeal carcinoma (NPC) has been suggested. Angiogenesis is a key step for metastasis. Thus, the association of LMP-1 to neovascularization of NPC was examined in this study.

Experimental Design: The association of LMP-1 to angiogenesis in 39 patients with NPC was evaluated by immunohistochemical study, and then induction of angiogenic factors by LMP-1 was examined by ELISA and luciferase reporter assay.

Results: In an immunohistochemical study, the expression of LMP-1 was significantly correlated to microvessel counts (P = 0.0003), suggesting that LMP-1 may induce some angiogenic factors. Therefore, we studied the relationship between LMP-1 expression and interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) expression by immunohistochemical analysis. IL-8, VEGF, and bFGF expression were correlated to microvessel counts, but only IL-8 expression was significantly correlated to LMP-1 expression (P < 0.0001). Transfection with LMP-1 expression plasmid induced IL-8 protein expression in C33A cells. The expression of LMP-1 transactivated IL-8 promoter, as demonstrated by IL-8 promoter luciferase reporter assay. Mutation of the nuclear factor {kappa}B responsive element in the IL-8 promoter region completely abolished transactivation by LMP-1, whereas mutation of the activator protein responsive element did not affect promoter activity.

Conclusion: These results suggested that LMP-1 induces expression of IL-8 through the nuclear factor {kappa}B binding site, which may contribute in part to angiogenesis in NPC.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Tsuji, N. Wakisaka, S. Kondo, S. Murono, M. Furukawa, and T. Yoshizaki
Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma
Clin. Cancer Res., September 1, 2008; 14(17): 5368 - 5375.
[Abstract] [Full Text] [PDF]


Home page
Lab AnimHome page
K.-P. N Chow, C C Wu, H Y Chang, C Chang, and Y S Chang
A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice
Lab Anim, April 1, 2008; 42(2): 193 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Hsu, S.-Y. Wu, S.-S. Chang, I.-J. Su, C.-H. Tsai, S.-J. Lai, A.-L. Shiau, K. Takada, and Y. Chang
Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells
J. Virol., April 1, 2008; 82(7): 3679 - 3688.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Horikawa, J. Yang, S. Kondo, T. Yoshizaki, I. Joab, M. Furukawa, and J. S. Pagano
Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma
Cancer Res., March 1, 2007; 67(5): 1970 - 1978.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. K. Hong, P. Kumar, L. Wang, B. Damania, M. L. Gulley, H.-J. Delecluse, P. J. Polverini, and S. C. Kenney
Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell Lines
J. Virol., November 15, 2005; 79(22): 13984 - 13992.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Wakisaka, S. Kondo, T. Yoshizaki, S. Murono, M. Furukawa, and J. S. Pagano
Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1{alpha}
Mol. Cell. Biol., June 15, 2004; 24(12): 5223 - 5234.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Melchjorsen, L. N. Sorensen, and S. R. Paludan
Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
J. Leukoc. Biol., September 1, 2003; 74(3): 331 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Lu, Y. Nakamoto, Y. Nemoto-Sasaki, C. Fujii, H. Wang, M. Hashii, Y. Ohmoto, S. Kaneko, K. Kobayashi, and N. Mukaida
Potential Interaction between CCR1 and Its Ligand, CCL3, Induced by Endogenously Produced Interleukin-1 in Human Hepatomas
Am. J. Pathol., April 1, 2003; 162(4): 1249 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, and J. S. Pagano
Epstein-Barr Virus Latent Membrane Protein 1 Induces and Causes Release of Fibroblast Growth Factor-2
Cancer Res., November 1, 2002; 62(21): 6337 - 6344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.